Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

NCT02977286 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Constipation

Interventions

DRUG: Naloxegol Oral Tablet
DRUG: Placebo Oral Tablet
DRUG: Docusate Sodium 100 Mg oral capsule [Colace]
DRUG: Senna 217 Mg Oral Tablet
DRUG: Polyethylene Glycols
DRUG: Bisacodyl 10 mg Suppository
DRUG: Magnesium Citrate Oral Liquid Product
DRUG: Methylnaltrexone

Sponsor

Tufts Medical Center